Evaluation of a Patient Navigation System to Reduce Time to Waitlisting for Potential Kidney Transplant Recipients
| Status: | Completed |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - 95 |
| Updated: | 2/24/2018 |
| Start Date: | January 2013 |
| End Date: | October 2017 |
The purpose of this study is to measure the effect of introducing a patient navigator to
guide high and moderate risk patients through the pre-waitlisting phases of the kidney
transplant process. Patients identified as being at high and moderate risk of delay to
waitlisting will be linked with a patient navigator, who will facilitate their completion of
pre-waitlisting requirements. We believe that patients who are randomized to a patient
navigator will be more likely to complete the pre-waitlisting process and will complete the
process more quickly than high and moderate risk patients who do not receive additional
assistance from a patient navigator.
guide high and moderate risk patients through the pre-waitlisting phases of the kidney
transplant process. Patients identified as being at high and moderate risk of delay to
waitlisting will be linked with a patient navigator, who will facilitate their completion of
pre-waitlisting requirements. We believe that patients who are randomized to a patient
navigator will be more likely to complete the pre-waitlisting process and will complete the
process more quickly than high and moderate risk patients who do not receive additional
assistance from a patient navigator.
The investigators plan to implement a newly developed risk assessment tool that uses medical
and demographic indicators to estimate the probability of waitlisting for all patients
beginning the transplant process at the Emory Transplant Center. Medical secretaries will
collect information about patients' medical and demographic characteristics during the
appointment scheduling phone call. This information will be entered into the REDCap risk
assessment tool, which will be used to calculate the probability of waitlisting. A previously
defined cut-off will be used to categorize the risk of delay to waitlisting.
A random subset of patients identified as being at high and moderate risk of delay to
waitlisting will be connected with a patient navigator, who will be available not only to
answer questions, but also to manage clinical information prior to, during, and following
transplantation. The navigator will work to identify potential barriers and to ensure that
the most up-to-date clinical information has garnered responses at the nurse and physician
levels.
The effect of connecting high and moderate risk patients with a patient navigator on time to
waitlisting and rate of waitlisting will be analyzed to determine whether such a program is
an effective means of increasing access to transplant for patients who are likely to face
financial, racial, and demographic barriers.
and demographic indicators to estimate the probability of waitlisting for all patients
beginning the transplant process at the Emory Transplant Center. Medical secretaries will
collect information about patients' medical and demographic characteristics during the
appointment scheduling phone call. This information will be entered into the REDCap risk
assessment tool, which will be used to calculate the probability of waitlisting. A previously
defined cut-off will be used to categorize the risk of delay to waitlisting.
A random subset of patients identified as being at high and moderate risk of delay to
waitlisting will be connected with a patient navigator, who will be available not only to
answer questions, but also to manage clinical information prior to, during, and following
transplantation. The navigator will work to identify potential barriers and to ensure that
the most up-to-date clinical information has garnered responses at the nurse and physician
levels.
The effect of connecting high and moderate risk patients with a patient navigator on time to
waitlisting and rate of waitlisting will be analyzed to determine whether such a program is
an effective means of increasing access to transplant for patients who are likely to face
financial, racial, and demographic barriers.
Inclusion Criteria:
- Kidney transplant candidates older than 18 years of age at Emory Transplant Center
Exclusion Criteria:
- There are no exclusion criteria that would limit subject participation
We found this trial at
1
site
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
Click here to add this to my saved trials
